[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1985

Correlation of the Vasoconstriction Assay and Clinical Activity in Psoriasis

Author Affiliations

From the Division of Dermatology, Scripps Clinic and Research Foundation, La Jolla, Calif (Dr Cornell); and the Department of Dermatology, School of Medicine, University of California, San Diego (Dr Stoughton).

Arch Dermatol. 1985;121(1):63-67. doi:10.1001/archderm.1985.01660010067020
Abstract

• A large group of glucocorticosteroid formulations were assayed by the vasoconstriction test in normal skin sites and paired comparison studies in patients with psoriasis. Excellent correlation between the vasoconstriction assay and selected paired comparison studies occurred in 20 of 23 instances. In three instances, involving two glucocorticosteroid formulations tested, correlation was absent. The vasoconstrictor assay is an inexpensive and reliable method for screening glucocorticosteroid formulations for clinical activity in psoriasis.

(Arch Dermatol 1985;121:63-67)

×